Thoracic Duct Injury After Modified Radical Neck Dissection (MRND)

Incidence & Anatomy

• Cummings Otolaryngology Head and Neck Surgery, p. 2324
• Scott-Brown's Otorhinolaryngology Head & Neck Surgery, p. 565

Fig. 119.9 - Chylous Fistula

Intraoperative Recognition & Management

• Ask the anesthesiologist to administer positive ventilatory pressure - this causes pooling of milky fluid or visualization of discrete lymph vessels.

• Meticulous ligation of the duct and all identifiable branches with non-absorbable sutures (e.g., silk)
• Use of the operating microscope for better visualization
• Adjunctive measures: fat grafting, application of Surgicel or a sclerosing agent to the region
• Mass ligation of all fatty tissue in the area (mass ligature of the "floor" of the dissection)

Postoperative Diagnosis

• Drain output changes from serosanguinous to milky/creamy - typically after resumption of oral feeding
• Drain fluid TG level >100 mg/dL AND greater than serum TG = diagnostic of chyle leak
• Drain fluid TG >110 mg/dL is diagnostic (Scott-Brown's)
• TG <50 mg/dL usually rules it out (unless fasted or malnourished)
• If TG is between 50-110 mg/dL, chylomicron analysis by electrophoresis is confirmatory

Management Algorithm

Step 1: Conservative Management (for low-output leaks)

1. Dietary modification (nutritional cornerstone):
   • Medium-chain triglyceride (MCT) diet - MCTs are absorbed directly into the portal circulation, bypassing the lymphatic system, thus dramatically reducing chyle flow
   • A fat-free or high-MCT enteral formula is used
   • Avoid long-chain triglycerides (LCTs) which enter the bloodstream via chyle
2. Pressure dressing over the neck wound to encourage skin-flap adherence and tamponade the leak
3. Closed drainage (keep the drain in situ) to promote adherence of flaps and monitor output
4. Somatostatin analogue - Octreotide:
   • Reduces splanchnic blood flow and GI chyle production
   • Administered subcutaneously or IV
   • Beneficial adjunct; a systematic review (PMID 36110865) supports its role in stopping post-surgical chyle leak
5. Orlistat (pancreatic lipase inhibitor, over-the-counter):
   • Reduces dietary fat absorption, thereby reducing chyle production
   • May be equally efficacious to octreotide in some cases

Step 2: Total Parenteral Nutrition (TPN)

• Indicated for very high output leaks (>1000 mL/24 hrs) or when dietary manipulation fails
• Eliminates enteral fat absorption entirely, giving the fistula opportunity to heal
• Should not be first-line unless extreme output

Step 3: Surgical/Interventional Re-exploration

• High-output leak (>500-1000 mL/24 hrs based on institutional threshold) not responding to conservative management
• Chyloma refractory to needle aspiration, pressure dressings, and dietary restriction
• Failure of conservative measures after ~2 weeks (most clinicians)

1. Re-exploration and surgical ligation - direct exploration of the neck wound, identification of the leaking duct/tributaries, and re-ligation with non-absorbable sutures +/- sclerosant/muscle flap placement
2. Percutaneous lymphangiography + embolization of the thoracic duct - promising for recalcitrant leaks; less invasive than open re-exploration
3. Video-assisted thoracoscopic surgery (VATS) ligation of the thoracic duct - recommended by some as preferred treatment for persistent chyle leaks; approaches the duct at the thoracic level

Management of Chylothorax (Rare Complication)

• Dietary modifications
• Thoracentesis or thoracostomy tube drainage
• Somatostatin analogue injection
• Rarely: thoracoscopic or open thoracotomy for thoracic duct ligation in the chest

Summary Algorithm

Thoracic Duct Injury Post MRND
        |
        +--> Intraoperative recognition?
        |         YES -> Positive pressure ventilation, meticulous ligation,
        |                non-absorbable sutures +/- Surgicel/sclerosant
        |
        +--> Postoperative (milky drain, TG >100 mg/dL)
                  |
                  +--> CXR to rule out chylothorax
                  |
                  +--> LOW OUTPUT (<500 mL/day):
                  |    MCT diet + pressure dressing + closed drain ± octreotide ± orlistat
                  |    -> Most will close spontaneously
                  |
                  +--> HIGH OUTPUT (>500-1000 mL/day):
                  |    Above + consider TPN
                  |    -> If no improvement in 5-7 days: surgical re-exploration
                  |
                  +--> REFRACTORY / CHYLOMA:
                       Percutaneous embolization OR VATS thoracic duct ligation

Recent Evidence

• A 2024 systematic review (PMID 37014458) on nutritional management of chyle leak after head and neck surgery proposed a structured protocol, reinforcing MCT-based dietary management as the cornerstone.
• A comprehensive 2024 review (PMID 38419516) in J Korean Assoc Oral Maxillofac Surg covers the full spectrum of diagnosis and management strategies.
• Octreotide's role is supported by a 2022 systematic review (PMID 36110865).

• Cummings Otolaryngology Head and Neck Surgery, pp. 2324-2325
• Scott-Brown's Otorhinolaryngology Head & Neck Surgery, p. 565